MK-3655 - Merck (MSD)
survodutide (BI 456906) - Boehringer Ingelheim
Rezdiffra (resmetirom) - Madrigal Pharma
efruxifermin (NN9062) - Novo Nordisk
Mounjaro (tirzepatide) - Eli Lilly
Zepbound (tirzepatide) - Eli Lilly
pegozafermin (RG6881) - Roche
lanifibranor (IVA337) - Inventiva, Hepalys Pharma
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=831836&rnd=0.1515598
 
Michael Leyderman; MD; Mohamed Eisa; MD
 
Aug 29, 2026
 
Prev Next